hypofractionated carbon ion therapy for unresectable retroperitoneal soft tissue sarcoma

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1800018041

Enrollment

Unknown

Registered

2018-08-28

Start date

2018-10-30

Completion date

Unknown

Last updated

2018-09-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

soft tissue sarcoma

Interventions

Case series:carbon ion therapy

Eligibility

Sex/Gender

All

Age

14 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1) Histologically confirmed retroperitoneal soft tissue sarcoma; 2) The patient refuses surgery or is deemed inoperable by the study surgeon; 3) Without lymph nodes or distant metastases; 4) Aged 14 to 70 years.

Exclusion criteria

Exclusion criteria: 1) Did not histologically confirmed retroperitoneal soft tissue sarcoma; 2) distant metastases; 3) Prior radiotherapy to the site of treatment; 4) pregnant woman.

Design outcomes

Primary

Measure	Time frame
Local control rate;	—

Secondary

Measure	Time frame
Overall survival;	—

Countries

China

Contacts

Public ContactQing Zhang

Shanghai Proton and Carbon ion Center

qing.zhang@sphic.org.cn+86 13917374609

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026